Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Acromegaly × lanreotide × Gastrointestinal × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 3 NET 1 Gastrointestinal 1

Conditions

Neuroendocrine Tumors 4 Gastro-enteropancreatic neuroendocrine tumor 4 Carcinoma, Hepatocellular 2 Carcinoid Tumor 2 Pancreatic Neoplasms 1 Neoplastic Cells, Circulating 1 Gastrointestinal Neoplasms 1 Adenoma, Islet Cell 1 Acromegaly 1

Interventions

lanreotide 1 Octreotide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05364944 2025-11-17

OXTEND-01

Debiopharm International SA

Phase 1 Terminated

EndocrineGastrointestinalNET

Gastro-enteropancreatic neuroendocrine tumor, Acromegaly

Data powered by HemOnc (CC BY 4.0) Colophon ⚡